These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study. Cordero-Ramos J; Barros-Tornay R; Toledo-Pastrana T; Ferrándiz L; Calleja-Hernández MÁ; Moreno-Ramírez D J Dermatol; 2022 Apr; 49(4):459-462. PubMed ID: 34984726 [TBL] [Abstract][Full Text] [Related]
9. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial. Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610 [TBL] [Abstract][Full Text] [Related]
10. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar. Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078 [TBL] [Abstract][Full Text] [Related]
11. Pilot study of fractional microneedling radiofrequency for hidradenitis suppurativa assessed by clinical response and histology. Yang JH; Cho SI; Kim DH; Yoon JY; Moon J; Kim JW; Choi S; Suh DH Clin Exp Dermatol; 2022 Feb; 47(2):335-342. PubMed ID: 34431555 [TBL] [Abstract][Full Text] [Related]